For type 2 diabetes management Both semaglutide and tirzepatide are FDA-approved for type 2 diabetes
He is an authority on the complex metabolic and hormonal changes (like GLP-1) that happen after bariatric surgery
NICE has appraised semaglutide (Wegovy, TA875) and liraglutide (Saxenda, TA664) as licensed options for weight management in eligible adults within specialist weight management services
diet and exercise, with a 90% probability of cost-effectiveness at a 20,000/QALY threshold (21)
Jeppesen DKAM, Fenix JL, Franklin, et al
So we have screening navigators, we have diagnostic navigators, and we have actual care trajectory navigators, which are oncology nurse navigators